Medicinal Products
Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju
Name |
Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju |
Marketing Authorisation Number |
HR-H-879693802 |
Active Substance |
irinotekanklorid trihidrat |
Composition |
1 ml koncentrata sadrži 20 mg irinotekanklorid trihidrata, što odgovara 17,33 mg irinotekana |
Pharmaceutical Form |
koncentrat za otopinu za infuziju |
Manufacturer |
Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska |
Marketing Authorisation Holder |
Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
Marketing Authorisation Date |
11.06.2021 |
MA Period of Validity |
unlimited |
Classification Number |
UP/I-530-09/20-02/108 |
Registration Number |
381-12-01/154-21-03 |
Prescription |
Medicinal product subject to medical prescription |
Type of prescription |
ograničeni recept
|
Distribution |
Supply through pharmacies (community) |
Advertising to general public |
not allowed |
ATC Code |
L01CE02 |
Marketing status |
stavljeno u promet |
Shortage status |
nema nestašice |
SmPC |
download |
PL |
download |
Public Assessment Report |
download
|
Packaging
Packaging description |
MA Number for Packaging |
Marketing status |
Shortage status |
1 bočica s 2 ml koncentrata, u kutiji |
HR-H-879693802-01 |
stavljeno u promet |
nema nestašice |
1 bočica s 5 ml koncentrata, u kutiji |
HR-H-879693802-02 |
stavljeno u promet |
nema nestašice |
1 bočica s 15 ml koncentrata, u kutiji |
HR-H-879693802-03 |
stavljeno u promet |
nema nestašice |
1 bočica s 25 ml koncentrata, u kutiji |
HR-H-879693802-04 |
stavljeno u promet |
nema nestašice |
1 bočica s 50 ml koncentrata, u kutiji |
HR-H-879693802-05 |
stavljeno u promet |
nema nestašice |
Direct Healthcare Professional Communication
Back